These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28549500)

  • 41. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.
    Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carotid intima-media thickness (IMT) in patients with severe familial and non-familial hypercholesterolemia: The effect of measurement site on the IMT correlation with traditional cardiovascular risk factors and calcium scores.
    Gałąska R; Kulawiak-Gałąska D; Chmara M; Chlebus K; Mickiewicz A; Rynkiewicz A; Wasąg B; Studniarek M; Fijałkowski M; Gruchała M
    Cardiol J; 2021; 28(2):271-278. PubMed ID: 32207844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
    Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender.
    Mattina A; Giammanco A; Giral P; Rosenbaum D; Carrié A; Cluzel P; Redheuil A; Bittar R; Béliard S; Noto D; Quartarone A; Averna M; Bruckert É; Gallo A
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1068-1076. PubMed ID: 31378630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
    Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of familial hypercholesterolemia in Taiwanese ischemic stroke patients.
    Tung H; Lin HJ; Chen PL; Lu TJ; Jhan PP; Chen JP; Chen YM; Wu CC; Lin YY; Hsiao TH
    Aging (Albany NY); 2021 Jul; 13(15):19339-19351. PubMed ID: 34314377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].
    Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F
    Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
    Huijgen R; Vissers MN; Kindt I; Trip MD; de Groot E; Kastelein JJ; Hutten BA
    Circ Cardiovasc Genet; 2011 Aug; 4(4):413-7. PubMed ID: 21642693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
    Neefjes LA; Ten Kate GJ; Alexia R; Nieman K; Galema-Boers AJ; Langendonk JG; Weustink AC; Mollet NR; Sijbrands EJ; Krestin GP; de Feyter PJ
    Atherosclerosis; 2011 Dec; 219(2):721-7. PubMed ID: 22018443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.
    Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
    Ten Kate GR; Bos S; Dedic A; Neefjes LA; Kurata A; Langendonk JG; Liem A; Moelker A; Krestin GP; de Feyter PJ; Roeters van Lennep JE; Nieman K; Sijbrands EJ
    J Am Coll Cardiol; 2015 Dec; 66(24):2687-2695. PubMed ID: 26700830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: A prospective multicenter study.
    Jeevarethinam A; Venuraju S; Dumo A; Ruano S; Mehta VS; Rosenthal M; Nair D; Cohen M; Darko D; Lahiri A; Rakhit R
    Clin Cardiol; 2017 Sep; 40(9):752-758. PubMed ID: 28543093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction.
    Khera AV; Chaffin M; Zekavat SM; Collins RL; Roselli C; Natarajan P; Lichtman JH; D'Onofrio G; Mattera J; Dreyer R; Spertus JA; Taylor KD; Psaty BM; Rich SS; Post W; Gupta N; Gabriel S; Lander E; Ida Chen YD; Talkowski ME; Rotter JI; Krumholz HM; Kathiresan S
    Circulation; 2019 Mar; 139(13):1593-1602. PubMed ID: 30586733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
    Escate R; Padró T; Pérez de Isla L; Fuentes F; Alonso R; Mata P; Badimon L
    Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
    Tada H; Takamura M; Kawashiri MA
    Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
    Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
    Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.